{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:27:09Z","timestamp":1765888029888,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3233-3","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T14:49:43Z","timestamp":1531320583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-2905","authenticated-orcid":false,"given":"Anuj","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steaven","family":"Dandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Djupuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Mieras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Hendrik","family":"Richardus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"3233_CR1","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1371\/journal.pmed.0020341","volume":"2","author":"A Rinaldi","year":"2005","unstructured":"Rinaldi A. The global campaign to eliminate leprosy. PLoS Med. 2005;2:e341.","journal-title":"PLoS Med"},{"key":"3233_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/003335490812300212","volume":"123","author":"BH Bennett","year":"2008","unstructured":"Bennett BH, Parker DL, Robson M. Leprosy: steps along the journey of eradication. Public Health Rep. 2008;123:198\u2013205.","journal-title":"Public Health Rep"},{"key":"3233_CR3","unstructured":"Daumerie D. Elimination of leprosy as a public health problem\u2014current status and challenges ahead, Scientific Working Group Report on leprosy: World Health Org; 2003. http:\/\/www.who.int\/lep\/resources\/SWG04.pdf . Accessed 13 Oct 2015."},{"key":"3233_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2471\/BLT.06.039206","volume":"85","author":"PEM Fine","year":"2007","unstructured":"Fine PEM. Leprosy: what is being \"eliminated\"? Bull World Health Organ. 2007;85:2. https:\/\/doi.org\/10.2471\/Blt.06.039206 .","journal-title":"Bull World Health Organ"},{"key":"3233_CR5","unstructured":"Global leprosy update, 2015: time for action, accountability and inclusion. Wkly Epidemiol Rec. 2016;91:405\u201320."},{"key":"3233_CR6","unstructured":"World Health Organization. Global Leprosy Programme. http:\/\/www.searo.who.int\/entity\/global_leprosy_programme\/leprosy_as_a_disease\/en\/ . Accessed 16 June 2016."},{"key":"3233_CR7","unstructured":"Central Bureau of Statistics. Indonesian Population by Province. 2012. https:\/\/www.bps.go.id\/linkTabelStatis\/view\/id\/1267 . Accessed 19 Apr 2016."},{"key":"3233_CR8","unstructured":"Central Bureau of Statistics. Percentage of Urban Population by Province 2010\u20132035, Indonesia. https:\/\/www.bps.go.id\/linkTabelStatis\/view\/id\/1276 . Accessed 19 Apr 2016."},{"key":"3233_CR9","first-page":"39","volume-title":"Reducing Maternal and Neonatal Mortality in Indonesia: Saving lives, saving the future","author":"The Indonesian Health Care System","year":"2013","unstructured":"The Indonesian Health Care System. Reducing Maternal and Neonatal Mortality in Indonesia: Saving lives, saving the future. Washington: National Academies Press (US); 2013. p. 39\u201352."},{"key":"3233_CR10","unstructured":"Global leprosy update, 2014: need for early case detection. Wkly Epidemiol Rec. 2015(90):461\u201374."},{"key":"3233_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s13071-015-1143-4","volume":"8","author":"DJ Blok","year":"2015","unstructured":"Blok DJ, De Vlas SJ, Richardus JH. Global elimination of leprosy by 2020: are we on track? Parasit Vectors. 2015;8:548.","journal-title":"Parasit Vectors"},{"key":"3233_CR12","unstructured":"Uniting to Combat NTDs. Country Leadership and Collaboration on Neglected Tropical Diseases: Third progress report of the London Declaration.. http:\/\/unitingtocombatntds.org\/sites\/default\/files\/document\/UTCNTD%20FULL%20REPORT.pdf Accessed 9 Apr 2016."},{"key":"3233_CR13","unstructured":"World Health Organization. Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap for Implementation. 2012. http:\/\/www.who.int\/neglected_diseases\/NTD_RoadMap_2012_Fullversion.pdf?ua =1. Accessed 16 June 2016."},{"key":"3233_CR14","doi-asserted-by":"publisher","unstructured":"WHv B, Sihombing B, Djarir H, Beise K, Kusumawardhani L. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Glob Health Action. 2012;5. https:\/\/doi.org\/10.3402\/gha.v5i0.18394 .","DOI":"10.3402\/gha.v5i0.18394"},{"key":"3233_CR15","unstructured":"Anastasia I. The Wall Street Journal. Leprosy Cases Decline in Indonesia, but Not Stigma. 2015. http:\/\/blogs.wsj.com\/indonesiarealtime\/2015\/01\/27\/leprosy-cases-decline-in-indonesia-but-not-stigma\/ . Accessed 9 Apr 2016."},{"key":"3233_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/261329","volume":"2015","author":"M Lusli","year":"2015","unstructured":"Lusli M, Zweekhorst MBM, Miranda-Galarza B, Peters RMH. Dealing with stigma: experiences of persons affected by disabilities and leprosy. Biomed Res Int. 2015;2015:1\u20139.","journal-title":"Biomed Res Int"},{"key":"3233_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.47276\/lr.83.3.221","volume":"83","author":"RH Gelber","year":"2012","unstructured":"Gelber RH, Grosset J. The chemotherapy of leprosy: an interpretive history. Lepr Rev. 2012;83:221\u201340.","journal-title":"Lepr Rev"},{"key":"3233_CR18","unstructured":"Global Leprosy Strategy 2016-2020: Accelerating towards a leprosy-free world. 2016. http:\/\/www.searo.who.int\/entity\/global_leprosy_programme\/documents\/global_leprosy_strategy_2020\/en\/ . Accessed 08 July 2018."},{"key":"3233_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clindermatol.2014.07.009","volume":"33","author":"JH Richardus","year":"2015","unstructured":"Richardus JH, Oskam L. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis. Clin Dermatol. 2015;33:19\u201325.","journal-title":"Clin Dermatol"},{"key":"3233_CR20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.47276\/lr.85.1.2","volume":"85","author":"WC Smith","year":"2014","unstructured":"Smith WC, Aerts A. Role of contact tracing and prevention strategies in the interruption of leprosy transmission. Lepr Rev. 2014;85:2\u201317.","journal-title":"Lepr Rev"},{"key":"3233_CR21","first-page":"487","volume":"65","author":"AA Louhenapessy","year":"1997","unstructured":"Louhenapessy AA, Zuiderhoek B. A practical method of active case finding and epidemiological assessment: its origin and application in the leprosy control project in Indonesia. Int J Lepr Other Mycobact Dis. 1997;65:487\u201391.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"3233_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4269\/ajtmh.2005.72.443","volume":"72","author":"MI Bakker","year":"2005","unstructured":"Bakker MI, Hatta M, Kwenang A. Prevention of leprosy using rifampicin as chemoprophylaxis. Am J Trop Med Hyg. 2005;72:443\u20138.","journal-title":"Am J Trop Med Hyg."},{"key":"3233_CR23","doi-asserted-by":"publisher","first-page":"e013633","DOI":"10.1136\/bmjopen-2016-013633","volume":"6","author":"T Barth-Jaeggi","year":"2016","unstructured":"Barth-Jaeggi T, Steinmann P, Mieras L, van Brakel W, Richardus JH, Tiwari A, et al. Leprosy post-exposure prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin. BMJ Open. 2016;6:e013633.","journal-title":"BMJ Open"},{"key":"3233_CR24","first-page":"810","volume":"57","author":"JL Cartel","year":"1989","unstructured":"Cartel JL, Chanteau S, Boutin JP, Taylor R, Plichart R, Roux J, et al. Implementation of chemoprophylaxis of leprosy in the southern Marquesas with a single dose of 25 mg per kg rifampin. Int J Lepr Other Mycobact Dis. 1989;57:810\u20136.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"3233_CR25","first-page":"416","volume":"60","author":"JL Cartel","year":"1992","unstructured":"Cartel JL, Chanteau S, Moulia-Pelat JP, Plichart R, Glaziou P, Boutin JP, et al. Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampin in the southern Marquesas; results after four years. Int J Lepr Other Mycobact Dis. 1992;60:416\u201320.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"3233_CR26","first-page":"S33","volume":"71 Suppl","author":"LN Nguyen","year":"2000","unstructured":"Nguyen LN, Cartel JL, Grosset JH. Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg\/kg dose of rifampicin. Results after 10 years. Lepr Rev. 2000;71 Suppl:S33\u20135. discussion S5\u20136","journal-title":"Lepr Rev"},{"key":"3233_CR27","first-page":"S30","volume":"67","author":"LJ Blanc","year":"1999","unstructured":"Blanc LJ. Summary of leprosy chemoprophylaxis programs in the western Pacific region. Int J Lepr Other Mycobact Dis. 1999;67:S30\u20131.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"3233_CR28","first-page":"S21","volume":"71 Suppl","author":"C Diletto","year":"2000","unstructured":"Diletto C, Blanc L, Levy L. Leprosy chemoprophylaxis in Micronesia. Lepr Rev. 2000;71 Suppl:S21\u20133. discussion S4\u20135","journal-title":"Lepr Rev"},{"key":"3233_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","volume":"336","author":"M FJ","year":"2008","unstructured":"FJ M, Pahan D, Oskam L, Richardus JH, Group CS. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ. 2008;336:761\u20134. https:\/\/doi.org\/10.1136\/bmj.39500.885752.BE .","journal-title":"BMJ"},{"key":"3233_CR30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.47276\/lr.83.3.292","volume":"83","author":"SG Feenstra","year":"2012","unstructured":"Feenstra SG, Pahan D, Moet FJ, Oskam L, Richardus JH. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh. Lepr Rev. 2012;83:292\u2013304.","journal-title":"Lepr Rev"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3233-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3233-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3233-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T16:05:33Z","timestamp":1604592333000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3233-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3233"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3233-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"21 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval not applicable. Post exposure prophylaxis with single dose of rifampicin is a routine strategy under National Leprosy Control Program (NLCP) of Indonesia. The study was conducted as a routine monitoring and evaluation activity of NLCP. A verbal consent was taken from all the participants, and from parents in case of minors. The information on refused consent is shown in Table\u00a0.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A verbal consent was taken from all the participants and data on declined consent were reported in the result section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"324"}}